Davenport & Co’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,363
| Closed | -$929K | – | 691 |
|
|
2018
Q3 | $929K | Sell |
11,363
-1,000
| -8% | -$81.8K | 0.01% | 330 |
|
|
2018
Q2 | $432K | Hold |
12,363
| – | – | 0.01% | 478 |
|
|
2018
Q1 | $254K | Buy |
12,363
+1,000
| +9% | +$20.5K | ﹤0.01% | 591 |
|
|
2017
Q4 | $322K | Hold |
11,363
| – | – | ﹤0.01% | 538 |
|
|
2017
Q3 | $353K | Hold |
11,363
| – | – | ﹤0.01% | 505 |
|
|
2017
Q2 | $360K | Sell |
11,363
-11,225
| -50% | -$355K | ﹤0.01% | 495 |
|
|
2017
Q1 | $493K | Hold |
22,588
| – | – | 0.01% | 408 |
|
|
2016
Q4 | $493K | Buy |
22,588
+11,225
| +99% | +$245K | 0.01% | 409 |
|
|
2016
Q3 | $300K | Hold |
11,363
| – | – | ﹤0.01% | 484 |
|
|
2016
Q2 | $224K | Buy |
+11,363
| New | +$224K | ﹤0.01% | 521 |
|